| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/13/2006 | WO2006073431A2 Avipox recombinants expressing foot and mouth disease virus genes |
| 07/13/2006 | WO2006073410A1 Compositions, methods and devices for preparing less painful botulinum toxin formulations |
| 07/13/2006 | WO2006073311A2 Treatment of ibd |
| 07/13/2006 | WO2006073052A1 Novel angiogensis inhibitor |
| 07/13/2006 | WO2006072803A2 Antibody |
| 07/13/2006 | WO2006072787A1 Compositions for immunizing against mycobacterium |
| 07/13/2006 | WO2006072626A1 Kir-binding agents and methods of use thereof |
| 07/13/2006 | WO2006072564A1 Antibodies against il-13 receptor alpha 1 and uses thereof |
| 07/13/2006 | WO2006072304A2 Tumor antigens for use in diagnosis and therapy |
| 07/13/2006 | WO2006072251A1 Method of preventive treatment of allergy by oromucosal administration of an allergy vaccine |
| 07/13/2006 | WO2006072202A1 A rantes-dt390 recombinant immunotoxin plasmid targeting activated th1 cells and production method and uses thereof |
| 07/13/2006 | WO2006072166A1 Cytotoxicity mediation of cells evidencing surface expression of cd63 |
| 07/13/2006 | WO2006050949A3 Superagonistic anti-cd28 antibody |
| 07/13/2006 | WO2006047670A3 Methods for assessing antibodies to neurodegenerative disease-associated antigens |
| 07/13/2006 | WO2006042149A3 Determining and reducing immunoresistance to botulinum toxin therapy using botulinum toxin a peptides |
| 07/13/2006 | WO2006042002A3 Compositions and methods for treating disease |
| 07/13/2006 | WO2006029300A3 Flavivirus variants having phenotypic variation and immunogenic compositions thereof |
| 07/13/2006 | WO2006020889A3 Dendritic cell vaccines for treating cancer made from embryonic stem cells |
| 07/13/2006 | WO2006009525A3 P. aeruginosa mucoid exopolysaccharide specific binding peptides |
| 07/13/2006 | WO2006008003A3 Diagnostics and therapeutics for diseases associated with vasoactive intestinal peptide receptor 1 (vpac1) |
| 07/13/2006 | WO2005117974B1 Cancer treatment method by inhibiting mage gene expression or function |
| 07/13/2006 | WO2005100403A3 Antibodies to erythropoietin receptor and uses thereof |
| 07/13/2006 | WO2005081749A3 Neutralizing human antibodies to anthraxtoxin |
| 07/13/2006 | WO2005077416A3 Lipid rafts and clostridial toxins |
| 07/13/2006 | WO2005032454A3 Anti-muc-1 single chain antibodies for tumor targeting |
| 07/13/2006 | WO2003095621A3 Apoptotic ebv-transformed lymphocytes, a therapeutic agent for post-transplant lymphoproliferactive disorder |
| 07/13/2006 | US20060155116 Hypoallergenic variants of the parietaria judaica major allergens, uses thereof and compostitions comprising them |
| 07/13/2006 | US20060155113 Replication protein |
| 07/13/2006 | US20060154890 Immunostimulatory nucleic acids for the treatment of asthma and allergy |
| 07/13/2006 | US20060154858 Canine rankl and methods for preparing and using the same |
| 07/13/2006 | US20060154857 G1 phase arresting compound is rapamycin and the HIV antiviral agent is T20 (enfuvirtide); enhances the activity of the antiviral agent |
| 07/13/2006 | US20060154853 Method of treating an autoimmune disease |
| 07/13/2006 | US20060154319 Inhibition of bradykinin release |
| 07/13/2006 | US20060154313 Human B7 polypeptide B7-H3A |
| 07/13/2006 | US20060154310 Detecting the presence of a prostate cancer cell expressing a protein SGP28; immunoassay |
| 07/13/2006 | US20060154285 Zebrafish heterotrimer G-protein gamma 2 subunit (GNG2) |
| 07/13/2006 | US20060154243 Antigenic peptides of SARS coronavirus and uses thereof |
| 07/13/2006 | US20060153921 Method for preparation of particles from solution-in-supercritical fluid or compressed gas emulsions |
| 07/13/2006 | US20060153884 can be associated with the peptide 111-136 of HARP; cancer treatment |
| 07/13/2006 | US20060153883 HM1.24-utilizing cancer vaccines |
| 07/13/2006 | US20060153882 Anti-allergic pharmaceutical composition containing at least one allergen and at least on antihistamine compound |
| 07/13/2006 | US20060153881 P. falciparum erythrocyte binding protein-2 (EBP2) Region II (RII), used to induce an immune response to Plasmodium falciparum merozoites to treat diseases such as malaria |
| 07/13/2006 | US20060153880 Administering a polynucleotide encoding a Mycrobacterium kansasii-derived alpha antigen; asthma, atopic dermatitis, allergic rhinitis, allergic conjunctivitis |
| 07/13/2006 | US20060153879 Streptococcal C5a peptidase vaccine |
| 07/13/2006 | US20060153878 Adhesin as immunogen against enterotoxigenic Escherichia coli |
| 07/13/2006 | US20060153877 Remedies for dissease with hypermyotonia |
| 07/13/2006 | US20060153876 Cell membrane translocation of regulated snare inhibitors, compositions therefor, and methods for treatment of disease |
| 07/13/2006 | US20060153875 Novel brachyspira hyodyseteriae vaccine |
| 07/13/2006 | US20060153874 Recombinant poxvirus comprising at least two compox ati promoters |
| 07/13/2006 | US20060153873 Smallpox vaccine |
| 07/13/2006 | US20060153872 Methods of producing influenza vaccine compositions |
| 07/13/2006 | US20060153871 vaccine comprising the virus; immunization; diagnostic method comprising contacting a physiological sample of an animal suspected of containing antiinfluenza virus antibodies with the claimed virus |
| 07/13/2006 | US20060153870 Method for the recovery of non-segmented, nagative-stranded RNA viruses from cDNA |
| 07/13/2006 | US20060153869 Multibacterial vaccines and uses thereof |
| 07/13/2006 | US20060153868 Process for the preparation of an improved Brucella strain plasmid to develop the strain and the vaccine comprising the said strain |
| 07/13/2006 | US20060153867 To modulate the activity of one or more protein kinase C isozymes |
| 07/13/2006 | US20060153866 Human immunodeficiency virus-1 group O/M envelope polypeptide fusion for use as evaluative tool in diagnosing viral infection |
| 07/13/2006 | US20060153865 Antigenic peptides |
| 07/13/2006 | US20060153864 truncated papillomavirus L1 protein consisting of an amino acid sequence having one or more carboxy terminal amino acid residues deleted from a full length L1 amino acid sequence, and amino acid residues from a second protein replacing deleted amino acid residues in the truncated L1 protein. |
| 07/13/2006 | US20060153863 Use of inactive immunosuppressive and/or angiogenic immunogenic proteins, for producing secretory IgA's |
| 07/13/2006 | US20060153862 Use of immunogenic immunosuppressive and/or angiogenic proteins which have been rendered inactive, process for their preparation and pharmaceutical or vaccinal uses |
| 07/13/2006 | US20060153861 BCR-ABL imatinib resistance-associated peptides and methods of use thereof |
| 07/13/2006 | US20060153860 Single chain Fv fragments which bind epidermal growth factor receptors and/or HER2 genes; pharmacokinetics |
| 07/13/2006 | US20060153859 Ganglioside-KLH conjugate vaccine with QS-21 |
| 07/13/2006 | US20060153858 Drug delivery of a liquid comprising an antigen such as tumor-associated antigen directly to an area of high lymphatic drainage or a lymphatic system of the mammal to induce an antigen-specific Cytotoxic T lymphocyte (CTL) response; sustained release |
| 07/13/2006 | US20060153857 Method of treating staphylococcus aureus infection |
| 07/13/2006 | US20060153856 Monoclonal antibodies that bind Pseudomona mucoid heteropolysaccharides; used in the diagnosis, prophylaxis and therapy of P. aeruginosa infection and related disorders (e.g., cystic fibrosis); enhance opsonophagocytic killing of multiple mucoid strains |
| 07/13/2006 | US20060153855 Prevention and treatment of the porcine reproductive and respiratory syndrome (PRRS) |
| 07/13/2006 | US20060153854 Antibody induced cell membrane wounding |
| 07/13/2006 | US20060153853 Cancers of the breast, prostate, colorectal, lung, thyroid, ovaries, and brain as well as in childhood leukaemias, glioblastomas, and neuroblastomas; Insulin-like Growth Factor Binding Protein (IGFBP) with reduced IGF (Insulin-like Growth Factor) release characteristics |
| 07/13/2006 | US20060153852 Novel human Jak2 kinase |
| 07/13/2006 | US20060153851 CLASP proteins |
| 07/13/2006 | US20060153850 Antibodies to M-CSF |
| 07/13/2006 | US20060153849 Methods of treatment with an antibody that suppresses growth differentiation factor-14 activity |
| 07/13/2006 | US20060153848 Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis |
| 07/13/2006 | US20060153847 Methods and compositions for treating, inhibiting and reversing disorders of the intervertebral disc |
| 07/13/2006 | US20060153846 Formulation of human antibodies for treating tnf-alpha associated disorders |
| 07/13/2006 | US20060153845 Method for correcting immune respones and medical agent |
| 07/13/2006 | US20060153844 Methods to trigger, maintain and manipulate immune responses by targeted administration of biological response modifiers into lymphoid organs |
| 07/13/2006 | US20060153843 Method of immunomodulation |
| 07/13/2006 | US20060153842 Immunosuppressive combination and its use in the treatment or prophylaxis or insulin-producing cell graft rejection |
| 07/13/2006 | US20060153841 Nucleotide sequence which hybridizes to the complement of the specific nucleic acid molecule over its full length under conditions of incubation and encodes a polypeptide which costimulates T cell proliferation in vitro |
| 07/13/2006 | US20060153840 Methods for preventing or treating a condition or a disease associated with angiogenesis |
| 07/13/2006 | US20060153839 Production of bispecific molecules using polyethylene glycol linkers |
| 07/13/2006 | US20060153838 Fc region variants |
| 07/13/2006 | US20060153837 Treating autoimmune diseases with humanized anti-CD401 antibodies |
| 07/13/2006 | US20060153836 Using monoclonal antibody specific for kidney injury-molecule-1 (KIM-1) to diagnose, prevent and treat cell proliferative and kidney disorders; immunotherapeutics |
| 07/13/2006 | US20060153835 Treatment of pre-eclampsia in pregnant women using targeted apheresis |
| 07/13/2006 | US20060153834 Purification of immunoglobulins using affinity chromatography and peptide ligands |
| 07/13/2006 | US20060153833 Anti hepatitis C virus antibody and uses thereof |
| 07/13/2006 | US20060153832 Immunomodulating polymers |
| 07/13/2006 | US20060153828 Plasmid-specific polypeptide found in Eschericha; splitting esterase inhibitor; antibodies |
| 07/13/2006 | US20060153827 Chimeric protein |
| 07/13/2006 | US20060153825 Use of protein histidine phosphatase |
| 07/13/2006 | US20060153821 Induction of tumor and viral immunity using antigen presenting cell co-culture products and fusion products |
| 07/13/2006 | US20060153806 Proteins involved in the regulation of energy homeostasis |
| 07/13/2006 | US20060153801 Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| 07/13/2006 | US20060153798 Methods and compositions for needleless delivery of macromolecules |
| 07/13/2006 | US20060153770 Method of treating tumors |
| 07/13/2006 | US20060153757 Apparatus and method for the isolation of produced particles as a suspension in a non-supercritical fluid |